{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:52:25Z","timestamp":1778817145931,"version":"3.51.4"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["IP2 PI000753-01"],"award-info":[{"award-number":["IP2 PI000753-01"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["CE-1304\u20136677"],"award-info":[{"award-number":["CE-1304\u20136677"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Netherlands Organization for Scientific Research","award":["916.11.179"],"award-info":[{"award-number":["916.11.179"]}]},{"name":"W. L. Gore & Associates, Inc."},{"DOI":"10.13039\/501100008645","name":"Terumo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ijcard.2020.05.042","type":"journal-article","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T20:37:57Z","timestamp":1590439077000},"page":"222-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Cilostazol and peripheral artery disease-specific health status in ambulatory patients with symptomatic PAD"],"prefix":"10.1016","volume":"316","author":[{"given":"Moghniuddin","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensey","family":"Gosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Safley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qurat-Ul-Ain","family":"Jelani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert D.","family":"Aronow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Mena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi H.","family":"Shishehbor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Dawn","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim G.","family":"Smolderen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ijcard.2020.05.042_bb0005","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2020.05.042_bb0010","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jama.292.4.453","article-title":"Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms","volume":"292","author":"McDermott","year":"2004","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.ijcard.2020.05.042_bb0015","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/ejvs.2001.1305","article-title":"Quality of life in patients with intermittent claudication using the World Health Organisation (WHO) questionnaire","volume":"21","author":"Breek","year":"2001","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"4","key":"10.1016\/j.ijcard.2020.05.042_bb0020","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0741-5214(02)00131-3","article-title":"The intermittent claudication questionnaire: a patient-assessed condition-specific health outcome measure","volume":"36","author":"Chong","year":"2002","journal-title":"J. Vasc. Surg."},{"issue":"12","key":"10.1016\/j.ijcard.2020.05.042_bb0025","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ijcard.2020.05.042_bb0030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.05.042_bb0035","first-page":"Cd003748","article-title":"Cilostazol for intermittent claudication","volume":"10","author":"Bedenis","year":"2014","journal-title":"Cochr. Database Systemat. Rev."},{"issue":"22","key":"10.1016\/j.ijcard.2020.05.042_bb0040","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.jacc.2018.09.041","article-title":"ACC\/AHA versus ESC guidelines for diagnosis and management of peripheral artery disease","volume":"72","author":"Kithcart","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2020.05.042_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.003860","article-title":"PORTRAIT (patient-centered outcomes related to treatment practices in peripheral arterial disease: investigating trajectories): overview of design and rationale of an international prospective peripheral arterial disease study","volume":"11","author":"Smolderen","year":"2018","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"2","key":"10.1016\/j.ijcard.2020.05.042_bb0050","first-page":"301","article-title":"The peripheral artery questionnaire: a new disease-specific health status measure for patients with peripheral arterial disease","volume":"147","author":"Spertus","year":"2004","journal-title":"Am. Heart J."},{"issue":"suppl_1","key":"10.1016\/j.ijcard.2020.05.042_bb0055","first-page":"A19221","article-title":"Abstract 19221: developing a clinical predication model for 1-year health status outcomes in peripheral arterial disease: insights from the PORTRAIT registry","volume":"136","author":"Smolderen","year":"2017","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ijcard.2020.05.042_bb0060","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/CIRCULATIONAHA.114.009867","article-title":"Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one-year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial","volume":"130","author":"Nordanstig","year":"2014","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.ijcard.2020.05.042_bb0065","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2017.02.064","article-title":"Underuse of prevention and lifestyle counseling in patients with peripheral artery disease","volume":"69","author":"Berger","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2020.05.042_bb0070","doi-asserted-by":"crossref","first-page":"254","DOI":"10.23736\/S0392-9590.16.03734-2","article-title":"Patterns and determinants of use of pharmacological therapies for intermittent claudication in PAD outpatients: results of the IDOMENEO study","volume":"36","author":"Cimminiello","year":"2017","journal-title":"Int. Angiol."},{"issue":"3","key":"10.1016\/j.ijcard.2020.05.042_bb0075","first-page":"457","article-title":"The use of cilostazol in patients with peripheral arterial disease: results of a national physician survey","volume":"57","author":"de Donato","year":"2016","journal-title":"J. Cardiovasc. Surg."},{"issue":"20","key":"10.1016\/j.ijcard.2020.05.042_bb0080","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1161\/CIRCULATIONAHA.114.011021","article-title":"Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database","volume":"130","author":"Subherwal","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.05.042_bb0085","author":"European Medicines Agency"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320306914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320306914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:49:27Z","timestamp":1759092567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527320306914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":17,"alternative-id":["S0167527320306914"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.05.042","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cilostazol and peripheral artery disease-specific health status in ambulatory patients with symptomatic PAD","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.05.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}